RARRES2 and hepatocellular carcinoma: Cycloheximide treatment revealed that the half-life of endogenous PTEN was prolonged by chemerin overexpression (Supplementary Figure S3F), which was consistent with reduced ubiquitination of PTEN in chemerin-overexpressing HCC cells.